"Stuart Smith Well, very good. Let's talk about - can you talk about Benchmark and how they factor into the top a nice growth agenda?
Shital Mars So we were approached by Benchmark about doing a capital raise and we worked with them and we agreed to $10 million capital raise and now we're working around the structure of that. How would it take place, what kind of materials and due diligence, we're in that process. The purpose of working with Benchmark and the amount of money that we think is necessary is all for growth and expansion. We want to be a NASDAQ company that makes sense. We want to be a company that's really changing the face of pharmacy, changing the face of healthcare and while we are growing and we are having organic growth and we are increasing our prescription count to really make a difference on this growth, to really accelerate this growth we need real capital and so we believe that Benchmark is going to be able to provide this and provide it with investors that are friendly, that understand our market, understand our shareholder base, that are looking to - that aren't toxic in any way."
Here's some of the recent transactions of The Benchmark Company, who has agreed to a $10 million capital raise for Progressive Care.
Market Data 
Markets 
AI
